Indiva is a licensed supplier of high quality, medical-grade cannabis located in London, Ontario; recognizing that many consumers are looking for alternatives to smoking, the company made a number of exciting strategic moves throughout 2018 to diversify its brand. The company went public in December of 2017, currently has $24 million on the balance sheet with a $46 million market cap, and its fully-funded facility expansion project is nearing completion.
*No cannabis products are manufactured and/or distributed by DeepCell. DeepCell licensed cannabis products are manufactured and distributed by DeepCell licensees with the appropriate state license(s).